SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-20-328234
Filing Date
2020-12-29
Accepted
2020-12-29 06:43:47
Documents
3
Period of Report
2020-12-29

Document Format Files

Seq Description Document Type Size
1 PREM14A d15357dprem14a.htm PREM14A 1791104
2 GRAPHIC g15357g31e90.jpg GRAPHIC 3771
3 GRAPHIC g15357g68r50.jpg GRAPHIC 47663
  Complete submission text file 0001193125-20-328234.txt   1863268
Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Filer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: PREM14A | Act: 34 | File No.: 001-38667 | Film No.: 201420233
SIC: 2834 Pharmaceutical Preparations